Overview

Efficacy of Bupivacain Local Infiltration for the Management of Pain During Cesarean Section

Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
0
Participant gender:
Female
Summary
This study aims to evaluate the effect of local administration of bupivacain in the cesarean section incision for postoperative pain control, using the visual analogue pain scale (VAS) and assessing the need for rescue analgesia after surgery.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Saint Thomas Hospital, Panama
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

- Gestational age ≥ 36 weeks

- Elective cesarean section

- Transverse segmental caesarean section Pfannenstiel type

- Spinal anesthesia

- Maternal age 18 to 45 years

- Any gravaparity

- Patient ASA I or II

Exclusion Criteria:

- Any patient who does not meet the inclusion criteria.

- Emergency cesarean section

- History of chronic or neuropathic pain

- Patient with cardiopulmonary disease

- Known allergies to the drugs used in the study

- Patient who does not wish to participate in the study